Dr. Pautier on Doxorubicin Plus Trabectedin in Soft Tissue Sarcoma
2 意见
• 07/18/23
0
0
嵌入
Patricia Pautier, MD, discusses the toxicity profile of doxorubicin with trabectedin in the phase 2 LMS-02 trial in patients with metastatic/advanced uterine and soft tissue leiomyosarcoma.
Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论